Tectonic CFO granted 24,250 options at $29.92
Tectonic Therapeutic’s CFO received a 24,250-share stock option grant with staged vesting through 2030.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tectonic Therapeutic, Inc. (TECX) reported that Chief Financial Officer Daniel Lochner received a grant of 24,250 employee stock options on September 3, 2026. The options have an exercise price of $29.92 per share and expire on September 2, 2036. According to the vesting terms, 1/8 vests on September 3, 2026, with the remaining shares vesting in 42 equal monthly installments beginning October 3, 2026, subject to his continued service.
Insider Trade Summary
Grant/Award: 24,250 shares
Grant/Award
1 txn
Insider
Lochner Daniel
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F1 | 24,250 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 24,250 contracts (Direct)
Footnotes (1)
- F1. 1/8th of the shares subject to the option vest on September 3, 2026 with the remaining shares subject to the option vesting in the following 42 equal monthly installments beginning on October 3, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Key Figures
Options granted: 24,250 options
Exercise price: $29.92 per share
Expiration date: September 2, 2036
+2 more
5 metrics
Options granted
24,250 options
Employee stock option grant to CFO on September 3, 2026
Exercise price
$29.92 per share
Exercise price of the employee stock options granted to the CFO
Expiration date
September 2, 2036
Option expiration for the CFO’s employee stock options
Initial vesting portion
1/8 of granted options
Vests on September 3, 2026, per vesting footnote
Remaining vesting period
42 monthly installments
Remaining options vest monthly beginning October 3, 2026
Key Terms
Employee Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Employee Stock Option (Right to Buy) financial
"security title is listed as Employee Stock Option (Right to Buy)"
exercise price financial
"conversion or exercise price is reported as 29.9200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option vest on September 3, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration date for the option is September 2, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TECX disclose for its CFO?
Tectonic Therapeutic disclosed that Chief Financial Officer Daniel Lochner received a grant of 24,250 employee stock options on September 3, 2026, giving him the right to buy common shares at a fixed exercise price if and when the options vest.
What is the exercise price of the new TECX stock options granted to the CFO?
The employee stock options granted to Tectonic Therapeutic’s CFO have an exercise price of $29.92 per share. This is the price at which he may purchase common stock upon exercise of vested options, subject to the vesting schedule and option terms.
How many TECX options did the CFO hold after this reported grant?
After the reported grant, Chief Financial Officer Daniel Lochner held 24,250 stock options related to this award, as shown by the total derivative securities beneficially owned following the transaction on the Form 4.
What is the vesting schedule for the TECX options granted to the CFO?
According to the footnote, 1/8 of the options vest on September 3, 2026. The remaining shares vest in 42 equal monthly installments beginning on October 3, 2026, subject to the CFO’s continued service to the company on each vesting date.
When do the newly granted TECX stock options expire?
The stock options granted to Tectonic Therapeutic’s CFO on September 3, 2026 carry an expiration date of September 2, 2036, after which any unexercised options will no longer be exercisable.
Were the TECX CFO’s option grants made under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not checked, and there is no footnote describing a trading plan, so these option grants are reported without reference to a Rule 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
